Skip to main content

Table 3 Function of several nanoparticles in viral respiratory infections

From: Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview

Type of the Viral Infection

Type of the Nanoparticle

Description

Ref

Influenza

TMC NPs

To successfully prevent this infection, purified HA2 and NP recombinant proteins were encapsulated in TMC NPs

[72]

H1N1

PS-GAMP

PS-GAMP significantly boosted H1N1 vaccine-induced humoral and cytotoxic T-cell immune responses in mice by imitating the primary stage of illness without causing further inflammation

[73]

H1N1

PEGylated ZnO-NPs

Exposure to the virus and bare ZnO-NPs at the highest non-toxic concentrations may result in a drop in viral titer

[74]

H3N2

AgNPs

The inhalation route used to inject AgNPs increases survival in H3N2-infected mice

[75]

H1N1

SeNPs

SeNPs inhibit lung damage in H1N1-infected mice and repress interactivity among virus and target cells

[76]

H1N1

IO-NPs

These NPs prevent the virus from connecting to target cells in vitro

[77]

RSV

AgNPs

Curcumin-modified AgNPs have more significant antiviral activity and a more effective inhibitory impact against respiratory syncytial virus (RSV) infection

[78]